Axa
PGEN icon

Axa’s Precigen PGEN Stock Holding History

Axa’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,000
Closed -$35.6K – 1133
2023
Q2 		$35.6K Buy
+31,000
New +$36.6K ﹤0.01% 1070
2023
Q1 		– Sell
-412,200
Closed -$627K – 1162
2022
Q4 		$627K Hold
412,200
– – ﹤0.01% 961
2022
Q3 		$874K Buy
412,200
+387,700
+1,582% +$818K ﹤0.01% 883
2022
Q2 		$32.8K Sell
24,500
-439,400
-95% -$652K ﹤0.01% 1106
2022
Q1 		$979K Buy
463,900
+401,300
+641% +$977K ﹤0.01% 958
2021
Q4 		$232K Buy
62,600
+45,700
+270% +$197K ﹤0.01% 1108
2021
Q3 		$84K Buy
+16,900
New +$97.3K ﹤0.01% 1213
2020
Q4 		– Sell
-305,400
Closed -$1.07M – 1327
2020
Q3 		$1.07M Sell
305,400
-133,708
-30% -$635K ﹤0.01% 932
2020
Q2 		$2.19M Hold
439,108
– – 0.01% 812
2020
Q1 		$1.49M Sell
439,108
-38,400
-8% -$166K 0.01% 787
2019
Q4 		$2.62M Buy
477,508
+157,400
+49% +$886K 0.01% 762
2019
Q3 		$1.83M Buy
320,108
+229,712
+254% +$1.56M 0.01% 881
2019
Q2 		$692K Buy
+90,396
New +$487K ﹤0.01% 1037

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Axa's PGEN Position: Q3 2023 in Review

Axa sold out of Precigen (PGEN) in Q3 2023, closing a stake of 31,000 shares — an estimated $35.6K sold.

Axa first reported a position in PGEN in Q2 2019 and held it in 13 quarters. The position peaked at $2.62M in Q4 2019. 138 funds tracked by Wall St. Rank hold PGEN as of Q3 2023.

  • Axa reported no remaining Precigen position as of Q3 2023 after selling out during the quarter.
  • Axa sold 31,000 Precigen shares in Q3 2023, an estimated $35.6K.
  • Axa first reported a position in Precigen in Q2 2019 and held it in 13 quarters.
  • Axa's Precigen position peaked at $2.62M in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.